Skip to main content

Table 4 Costs, QALYs, and ICER of three intervention strategies

From: Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea

 

Costs (USD)

Incremental costs

QALYs

Incremental QALYs

ICER

PHBPP (reference)

28,236,374

–

8,462,686

–

–

PHBPP with antiviral prophylaxis

29,561,401

1,325,027

8,462,768

82

16,159

Universal vaccination

29,312,011

1,075,637

8,461,656

− 1030

(Dominated)

  1. PHBPP Perinatal Hepatitis B Prevention Program, QALY quality-adjusted life years, ICER incremental cost-effectiveness ratio
Back to article page

Cost Effectiveness and Resource Allocation

ISSN: 1478-7547

Contact us